Fundraising Fox
David Bonita
InvestorGeneral Partner at OrbiMed
New York, New York
Writes $1M – $75M checks · typically $4M
Find your path to David
Sign up to see every warm intro you have to David
- Paths you didn't know you had: your email and LinkedIn already hold routes to David. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
David Bonita is a physician-investor (MD, Harvard; clinical work at Mass General) with over two decades investing, rising to General Partner in 2020, and board roles in oncology and therapeutics.
Invests in
AI & Machine LearningBiotechHealthtechMedical Devices
Deals · 10
ThrombolexBoard seat
via OrbiMed · filed Mar 2026 · $51.1M raise
Treeline BiosciencesBoard seat
via OrbiMed · filed Sep 2025 · $250M raise
Ikena Oncology, Inc.Board seat
via OrbiMed · filed Jul 2025 · $75M raise
Acutus MedicalBoard seat
via OrbiMed · filed Jul 2022 · $4.2M raise
Prelude TherapeuticsBoard seat
via OrbiMed · filed Jul 2016 · $5M raise
Clementia PharmaceuticalsBoard seat
via OrbiMed · filed Jul 2015 · $60M raise
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Board seats
Investor
Ambit BiosciencesCongruence TherapeuticsLoxo OncologyMagenta MedicalRampart BioscienceRepare TherapeuticsSublimity TherapeuticsThird Harmonic BioWindward Bio
Sources: SEC Form D filings · curated public sources.
Colleagues at OrbiMed
Network4
Investors connected to David in public investor directories — a warm-intro map.
Frequently asked questions
- Who is David Bonita?
- David Bonita is a physician-investor (MD, Harvard; clinical work at Mass General) with over two decades investing, rising to General Partner in 2020, and board roles in oncology and therapeutics.
- Where does David Bonita work?
- David Bonita is General Partner at OrbiMed.
- What does David Bonita invest in?
- David Bonita invests in AI & Machine Learning, Biotech, Healthtech, Medical Devices.
- What check size does David Bonita write?
- David Bonita typically writes checks of $1M – $75M.
- What boards does David Bonita sit on?
- David Bonita holds tracked board seats at Acutus Medical, Adela, Clementia Pharmaceuticals, Ikena Oncology, Inc., Imara, Prelude Therapeutics, SI-BONE, Thrombolex, Treeline Biosciences, Tricida.
- What companies has David Bonita invested in?
- Investments tracked here include Ambit Biosciences, Clementia Pharmaceuticals, Congruence Therapeutics, Imara, Loxo Oncology, Magenta Medical, Rampart Bioscience, Repare Therapeutics, SI-BONE, Sublimity Therapeutics, Third Harmonic Bio, Tricida, and 1 more.
About this profile. Compiled from public sources — OrbiMed's own website, regulatory filings and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights